Celldex Therapeutics, Inc.

CLDX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Jun 9, 2025
4 Jun 9, 2025
4 Jun 9, 2025
4 Jun 9, 2025
4 Jun 9, 2025
4 Jun 9, 2025
S-8 Jun 6, 2025 FORM S-8
3 Jun 6, 2025 OWNERSHIP DOCUMENT
8-K Jun 6, 2025 FORM 8-K
SCHEDULE 13G/A May 15, 2025
SCHEDULE 13G/A May 12, 2025
10-Q May 8, 2025 10-Q
8-K May 8, 2025 FORM 8-K
ARS Apr 21, 2025 ARS
DEF 14A Apr 21, 2025 FORM DEF 14A
SCHEDULE 13G/A Apr 17, 2025
SCHEDULE 13G Apr 10, 2025
10-K Feb 27, 2025 10-K
8-K Feb 27, 2025 FORM 8-K
SCHEDULE 13G/A Feb 14, 2025
SCHEDULE 13G Feb 14, 2025
SCHEDULE 13G/A Feb 12, 2025
SCHEDULE 13G/A Feb 5, 2025
4 Nov 20, 2024
SC 13G/A Nov 14, 2024
← Newer Page 4 of 49 · 1221 filings Older →